Abstract
From studies in lower animals, it is believed that deficiency of folic acid during the intrauterine period may lead to an infant’s being born mentally retarded.(1) The use of antimetabolites to folic acid is known to produce abortion in woman and also to produce a fetus with central nervous system and other deformities.(2,3) Work by Arakawa’s group(4) in Japan suggests that congenital enzyme defects in folate metabolism result in infants born with mental retardation, dilation of the cerebral ventricles, and intracerebral calcification. There is as yet no clear evidence that folate deficiency in adults produces histologically demonstrable damage to the central nervous system. However, folate deficiency in adults is associated with irritability and forgetfulness.(5) Furthermore, it has been suggested, most recently by Reynolds,(6) that anticonvulsants act in part by interfering with folate metabolism and that the supplying of folic acid increases fit frequency in patients whose convulsions would otherwise have been better controlled by anticonvulsant medication. This chapter will review what is known about the mechanisms whereby deficiency of folic acid may produce these alleged effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
V. Herbert, Inborn errors in folate metabolism—a cause of mental retardation? Ann. Int. Med. 68:956–958, 1968.
J. B. Thiersch, Therapeutic abortions with folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A.) administered by oral route, Am. J. Obstet. Gynecol. 63:1298–1304, 1952.
J. B. Thiersch, The control of reproduction in rats with the aid of antimetabolites and early experiences with antimetabolites as abortifacient agents in man, Acta Endocrinol. 23:37–45, 1956 (Suppl. 28).
T. Arakawa, Congenital defects in folate utilization, Am. J. Med. 48:594–598, 1970.
V. Herbert, Experimental nutritional folate deficiency in man, Trans. Ass. Am. Physicians 75:307–320, 1962.
E. H. Reynolds, Mental effects of anticonvulsants, and folic acid metabolism, Brain 91:197–214, 1968.
M. Victor and A. Lear, Subacute combined degeneration of the spinal cord: Current concepts of the disease process. Value of serum vitamin B12determinations in clarifying some of the common clinical problems, Am. J. Med. 20:896, 1956.
V. Herbert, “The Megaloblastic Anemias,” Grune & Stratton, New York, 1959.
C. E. Oxnard and W. T. Smith, Neurological degeneration and reduced serum vitamin B12-levels in captive monkeys, Nature 210:507, 1966.
S. S. Pant, A. K. Asbury, and E. P. Richardson, Jr., The myelopathy of pernicious anemia: A neurological reappraisal, Acta Neurol. Scand. 44:1–36, 1968 (Suppl. 35).
V. Herbert, Studies of folate deficiency in man, Proc. Roy. Soc. Med. (London) 57:377–384, 1964.
M. Levitt, P. F. Nixon, J. H. Pincus, and J. R. Bertino, Transport characteristics of folates in cerebrospinal fluid; a study utilizing doubly labeled 5-methyltetrahydrofolate and 5-formyltetrahydrofolate, J. Clin. Invest. 50:1301–1308, 1971.
H. Sobotka, H. Baker, and O. Frank, Vitamin levels in normal cerebrospinal fluid, Proc. Soc. Exptl. Biol. Med. 103:801–802, 1960.
V. Herbert and R. Zalusky, Selective concentration of folic acid activity in cerebrospinal fluid, Fed. Proc. 20:453, 1961.
V. Herbert and L. W. Sullivan, Activity of coenzyme B12in man, Ann. N. Y. Acad. Sci. 112:855–870, 1964.
F. M. Huennekens, Folate and B12coenzymes, in“Biological Oxidations” (T. P. Singer, ed.), pp. 439–513, Interscience Publishers, New York, 1968.
R. L. Blakley, “The Biochemistry of Folic Acid and Related Pteridines,” John Wiley & Sons, Inc., New York, 1969.
H. Weissbach and R. T. Taylor, Roles of vitamin B12 and folic acid in methionine synthesis, Vitamins & Hormones 28:415–440, 1970.
V. Herbert, Drugs effective in megaloblastic anaemias: Vitamin B12and folic acid, in“The Pharmacological Basis of Therapeutics” (L. S. Goodman and A. Gilman, ed.), 4th ed., pp. 1414–1444, Macmillan, New York, 1970.
V. Herbert (guest ed.), Symposium on vitamin B12and folate, Am. J. Med. 48:539–617, 1970.
V. Herbert, Recent developments in cobalamin metabolism, in“The Cobalamins” (H. R. V. Arnstein and R. J. Wrighton, eds.), pp. 2–16, J. & A. Churchill, Ltd., London, 1971.
V. Herbert, Folic acid and vitamin B12, in“Modern Nutrition in Health and Disease” (R. S. Goodhart and M. Shils, ed.), 5th ed., Lea & Febiger, Philadelphia, 1972.
P. Lanzkowsky, Congenital malabsorption of folate, Am. J. Med. 48:580–583, 1970.
A. L. Luhby and J. M. Cooperman, Congenital megaloblastic anemia and progressive central nervous system degeneration. Further clinical and physiological characterization and therapy of syndrome due to inborn error of folate transport, American Pediatric Society, Inc., Annual Meeting, Atlantic City, April 1967.
I. Chanarin, J. Laidlaw, L. W. Loughridge, and D. L. Mollin, Megaloblastic anemia due to phenobarbitone, the convulsant action of therapeutic doses of folic acid, Brit. Med. J. 1:1099, 1960.
T. F. Walters, Congenital megaloblastic anemia responsive to N 5-formyltetrahydrofolic acid administration, J. Pediat. 70:686, 1967.
J. Metz, R. Zalusky, and V. Herbert, Folic acid binding by serum and milk, Am. J. Clin. Nutrition 21:289–297, 1968.
FAO/WHO Expert Group, “Requirements of Ascorbic Acid, Vitamin D, Vitamin B12 Folate, and Iron,” WHO Technical Report Series, No. 452, 1970 (available for $1.25 from World Health Organization Distribution and Sales, Geneva, Switzerland).
J. C. Woodard and P. M. Newberne, Relation of vitamin B12and one-carbon metabolism to hydrocephalus in the rat, J. Nutrition 88:375, 1966.
A. G. Hogan, B. L. O’Dell, and J. R. Whitley, Maternal nutrition and hydrocephalus in newborn rats, Proc. Soc. Exptl. Biol. Med. 74:293, 1950.
B. Hoogstraten, J. Cuttner, and B. Natovitz, Sequence of recovery from multiple manifestations of folic acid deficiency, J. Mount Sinai Hosp. N.Y. 31:10–16, 1964.
C. E. Butterworth, Jr., Personal communication.
R. W. Strachan and J. G. Henderson, Dementia and folate deficiency, Quart. J. Med. 36:189–204, 1967.
E. H. Reynolds, J. M. Preece, J. Bailey, and A. Coppen, Folate deficiency in depressive illness, Brit. J. Psychiat. 117:287–292, 1970.
M. W. Carney, Serum folate values in 432 psychiatric patients, Brit. Med. J. 4:512–516, 1967.
R. Hunter, M. Jones, T. G. Jones, and D. M. Matthews, Serum B12and folate concentrations in mental patients, Brit. J. Psychiat. 113:1291–1295, 1967.
H. A. Hansen, P. Nordquist, and P. Sourander, Megaloblastic anemia and neurologic disturbances combined with folic acid deficiency, Acta Med. Scand. 176:243–251, 1964.
H. C. Grant, A. V. Hoffbrand, and D. G. Wells, Folate deficiency and neurological disease, Lancet 2:763–767, 1965.
R. H. Girdwood, Folic acid, its analogs and antagonists, Advan Clin. Chem. 3:235–297, 1960.
V. Herbert and R. Zalusky, Interrelations of vitamin B12and folic acid metabolism: Folic acid clearance studies, J. Clin. Invest. 41:1263–1276, 1962.
F. A. Klipstein, Subnormal serum folate and macrocytosis associated with anticonvulsant drug therapy, Blood 23:68–86, 1964.
I. Chanarin, “The Megaloblastic Anemias,” Blackwell, Oxford, F. A. Davis Co., Philadelphia, 1969.
E. H. Reynolds, Iatrogenic disorders in epilepsy, in“Modern Trends in Neurology” (J. Williams, ed.), pp. 271–286, Butterworths, London, 1970.
E. H. Reynolds, G. Milner, D. M. Matthews, and I. Chanarin, Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism, Quart. J. Med. 35:521–537, 1966.
E. H. Reynolds, I. Chanarin, G. Milner, and D. M. Matthews, Anticonvulsant therapy, folic acid and vitamin B12metabolism and mental symptoms, Epilepsia (Amsterdam) 7:261–270, 1966.
E. H. Reynolds, Effects of folic acid on the mental state and fit frequency of drug-treated epileptic patients, Lancet 1:1086–1088, 1967.
D. G. Wells and H. Casey, Lactobacillus caseiC. S. F. folate activity, Brit. Med. J. 3:834–837, 1967.
E. H. Reynolds, J. Preece, and I. Chanarin, Folic acid and anticonvulsants, Lancet 1:1264–1265, 1969.
I. H. Rosenberg, H. A. Godwin, R. R. Streiff, and W. B. Castle, Impairment of intestinal deconjugation of dietary folate. A possible explanation of megaloblastic anemia associated with Phenytoin therapy, Lancet 2:530–532, 1968.
A. V. Hoffbrand and T. F. Necheles, Mechanism of folate deficiency in patients receiving Phenytoin, Lancet 2:528–530, 1968.
C. M. Baugh and C. L. Krumdieck, Effects of Phenytoin on folic acid conjugases in man, Lancet 2:519–521, 1969.
L. H. Bernstein, S. Gutstein, S. Weiner, and G. Efron, The absorption and malabsorption of folic acid and its polyglutamates, Am. J. Med. 48:570–579, 1970.
C. D. Gerson, N. Cohen, G. W. Hepner, N. Brown, V. Herbert, and H. D. Janowitz, Folic acid absorption in man: Enhancing effect of glucose, Gastroenterology 61:224–227, 1971.
G. W. Hepner, L. M. Aledort, D. C. Gerson, N. Cohen, V. Herbert, and H. D. Janowitz, Inhibition of intestinal ATPase by diphenylhydantoin and acetazolamide, Clin. Res. 18:382, 1970.
S. Momtazi and V. Herbert, Studying mechanisms of intestinal absorption using suspensions of vibration-obtained individual small bowel epithelial cells: folate absorption, Am. J. Clin. Nutrii. 25:449–450, 1972.
G. Tisman and V. Herbert, Inhibition by human serum, dilantin (diphenylhydantoin), and methotrexate (MTX), and enhancement by 2-deoxyglucose of 3H-pteroylglutamic acid (3HPGA) and 3H-5-methyltetrahydrofolate (M-THF) uptake by human bone marrow cells in vitro, Clin. Res. 19:433, 1971 (Abst.).
D. M. Woodbury and J. W. Kemp, Some possible mechanisms of action of anti-epileptic drugs, in“Pharmakopsychiatrie Neuro-Psychopharmakologie. Advances in Theoretical and Clinical Research” (H. Coper, M. Engelmeier, K. Heinrich, A. Herz, H. Hippins, and P. Kielholz, eds.), pp. 201–226, Georg Thieme Verlag, Stuttgart, 1970.
B. W. Festoff and S. H. Appel, Effect of diphenylhydantoin on synaptosome sodium-potassium-ATPase, J. Clin. Invest. 47:2752, 1968.
S. Waxman, J. Corcino, and V. Herbert, Drugs, toxins and dietary amino acids affecting vitamin B12 or folic acid absorption or utilization, Am. J. Med. 48:599–608, 1970.
J. S. Malpas, G. H. Spray, and L. J. Witts, Serum folic acid and vitamin B12 levels in anticonvulsant therapy, Brit. Med. J. 1:955–957, 1966.
E. H. Reynolds, I. Chanarin, G. Milner, and D. M. Matthews, Anticonvulsant therapy, folic acid and vitamin B12metabolism and mental symptoms, Epilepsia (Amsterdam) 7:261–270, 1966.
R. J. Harrison, Vitamin B12levels in erythrocytes in anaemia due to folate deficiency, Brit. J. Haematol. 20:623–628, 1971.
V. Herbert, G. Tisman, L. T. Go, and L. Brenner, B12-dependence of cell uptake of serum folate: an explanation for high serum folate and cell folate depletion in B12deficiency, Clin. Res. 20:489, 1972.
R. P. Snaith, S. Mehta, and A. H. Raby, Serum folate and vitamin B12in epileptics with and without mental illness, Brit. J. Psychiat. 116:179–183, 1970.
V. Bonavita, P. Monaco, and E. Tripi, Analisi degli effetti centrali di nucleotidi purinici e pirimidinici e loro derivati, Acta Neurol. 19:215–222, 1964.
F. Piccoli, R. Camarda, and V. Bonavita, Purine and pyrimidine nucleotides in the brain of normal and convulsant rats, J. Neurochem. 16:159–169, 1969.
V. Bonavita and F. Piccoli, Brain nucleotides and excitatory processes, in“Advances in Experimental Medicine and Biology” (R. Paoletti, ed.), Vol. 13, pp. 355–373, Plenum Press, New York, 1971.
E. H. Reynolds, J. M. Preece, J. Bailey, and A. Coppen, Folate deficiency in depressive illness, Brit. J. Psychiat. 117:287–292, 1970.
R. Hunter, J. Barnes, H. F. Oakeley, and D. M. Matthews, Toxicity of folic acid given in pharmacologic doses to healthy volunteers, Lancet 1:61–64, 1970.
F. B. Gibberd, A. Nicholls, J. F. Dunne, and D. M. Chaput de Saintonge, Toxicity of folic acid, Lancet 1:360–361, 1970.
J. H. Pincus, I. Grove, B. B. Marino, and G. E. Glaser, Studies on the mechanism of action of diphenylhydantoin, Arch. Neurol. 22:566–571, 1970.
R. R. Streiff, B. J. Wilder, and R. Hammer, Folic acid and diphenylhydantoin toxicity, in“Proceedings of a Symposium on the Pharmacology of Antiepileptic Drugs” (J. Penry, ed.), National Institutes of Health Monograph, to be published June 1972, by Raven Press.
H. Kutt, W. Winters, and F. H. McDowell, Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapy, Neurology 16:594–602, 1966.
D. M. Shaw, D. A. Macsweeney, A. L. Johnson, R. O’Keefe, D. Naidoo, D. M. Macleod, S. Jog, J. M. Preece, and J. M. Crowley, Folate and amine metabolites in senile dementia: A combined trial and biochemical study, Psychol. Med. 1:166–171, 1971.
H. E. M. Kay, P. J. Knapton, J. P. O’Sullivan, D. G. Wells, R. F. Harris, E. M. Innes, J. Stuart, F. C. M. Schwartz, and E. N. Thompson, Severe neurological damage associated with methotrexate therapy, Lancet 2:542, 1971.
D. Pinkel, K. Hernandez, L. Borella, C. Holton, R. Aur, G. Samoy, and C. Pratt, Drug dosage and remission duration in childhood lymphocytic leukemia, Cancer 27:247–256, 1971.
S. H. Mudd, H. L. Levy, and R. H. Abeles, A derangement in B12metabolism leading to homocystinemia, cystathioninemia and methylmalonic aciduria, Biochem. Biophys. Res. Commun. 35:121–126, 1969.
M. J. Mahoney and L. E. Rosenberg, Inherited defects of B12metabolism, Am. J. Med. 48:584 – 593, 1970.
G. Morrow, III, L. A. Barness, V. H. Auerbach, A. M. DiGeorge, T. Ando, and W. L. Nyhan, Observations on the coexistence of methylmalonic acidemia and glycinemia, J. Pediat. 74:680, 1969.
G. Morrow, III, L. A. Barness, G. J. Cardinale, R. H. Abeles, and J. G. Flaks, Congenital methylmalonic acidemia: Enzymatic evidence for two forms of the disease, Proc. Natl. Acad. Sci. 63:191, 1969.
H. Baker, O. Frank, I. Pasher, H. Ziffer, and H. Sobotka, Pantothenic acid, thiamine and folic acid levels at parturition, Proc. Soc. Exptl. Biol. Med. 103:321–323, 1960.
M. Jadhav, J. K. G. Webb, and S. J. Baker, Vitamin B12deficiency in Indian infants, Lancet 1:720, 1963.
J. J. Corcino, S. Waxman, and V. Herbert, Absorption and malabsorption of vitamin B12, Am. J. Med. 48:562–569, 1970.
E. V. Cox, D. Robertson-Smith, M. Small, and A. M. White, The excretion of propionate and acetate in vitamin B12deficiency, Clin. Sci. 35:123, 1968.
E. P. Frenkel, Studies on mechanism of the neural lesion of pernicious anemia, J. Clin. Invest. 50:33a, 1971.
A. J. Marcus, H. L. Ullman, L. B. Safier, and H. S. Ballard, Platelet phosphatides. Their fatty acid and aldehyde composition and activity in different clotting systems, J. Clin. Invest. 41:2198–2212, 1962.
K. C. Smithburn and L. G. Zerfas, The neural symptoms and signs in pernicious anemia, Arch. Neurol. Psychiat. 25:1110, 1931.
H. H. Hyland, G. O. Watts, and R. F. Farquharson, Course of subacute combined degeneration of spinal cord, Can. Med. Ass. J. 65:295, 1951.
J. Richmond and S. Davidson, Subacute combined degeneration of the spinal cord in non-addisonian megaloblastic anaemia, Quart. J. Med. 27:517, 1958.
S. Davidson, Clinical picture of pernicious anemia prior to introduction of liver therapy in 1926 and in Edinburgh subsequent to 1944, Brit. Med. J. 1:241, 1957.
J. G. Greenfield and E. A. Carmichael, The peripheral nerves in cases of subacute combined degeneration of the cord, Brain 58:483, 1935.
W. M. Van Der Scheer and H. C. Koek, Peripheral nerve lesions in cases of pernicious anemia, Acta Psychiat Neurol. 13:61, 1938.
E. C. C. Jewesbury, Subacute combined degeneration of the cord and achlorhydric peripheral neuropathies without anaemia, Lancet 2:307, 1954.
J. M. Holmes, Cerebral manifestation of vitamin B12deficiency, Brit. Med. J. 2:1394, 1956.
M. M. Wintrobe, “Clinical Hematology,” Philadelphia, Lea & Febiger, 1956.
W. B. Castle, The anemias, in“A Textbook of Medicine” (R. L. Cecil and R. F. Loeb, eds.), 10th ed., W. B. Saunders, Co., Philadelphia, 1959.
C. C. Ungley, Treatment with vitamin B12in haematologic disorders, in“Vitamin B12and Intrinsic Factor” (H. C. Heinrich, ed.), Ferdinand Enke Verlag, Stuttgart, 1957.
J. M. Heaton, A. J. A. McCormick, and A. G. Freeman, Tobacco amblyopia: A clinical manifestation of vitamin B12deficiency, Lancet 2:286, 1958.
H. E. Hamilton, P. P. Ellis, and R. F. Sheets, Visual impairment due to optic neuropathy in pernicious anemia. Report of a case and review of the literature, Blood 14:378, 1959.
C. E. C. Harris, Snares and delusions in the recognition of “pernicious anemia,” Connecticut Med. J. 12:543, 1958.
Von W. Gassmann and J. Schneeweiss, Diabetes mellitus und perniziose Anamie, Acta Haematol. 16:396, 1956.
G. Panzram, Pernicious anemia and diabetes mellitus, Z. Ges. Inn. Med. Leipzig 15:239, 1960.
H. Keen and R. Smith, Vitamin B12and the course of diabetic retinopathy, Lancet 1:849, 1956.
R. Shulman, A survey of vitamin B12deficiency in an elderly psychiatric population, Brit. J. Psychiat. 113:241–251, 1967.
G. J. Henderson, R. W. Strachan, J. Swanson Beck, A. A. Dawson, and M. Daniel, The antigastric-antibody test as a screening procedure for vitamin B12deficiency in psychiatric practice, Lancet 2:809–813, 1966.
E. Edwin, K. Holten, K. R. Norum, A. Schrumpf, and O. E. Skaug, Vitamin B12hypovitaminosis in mental disease, Acta Med. Scand. 177:689–699, 1965.
R. Shulman, Psychiatric aspects of pernicious anaemia: A prospective controlled investigation, Brit. Med. J. 3:266–270, 1967.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1973 Plenum Press, New York
About this chapter
Cite this chapter
Herbert, V., Tisman, G. (1973). Effects of Deficiencies of Folic Acid and Vitamin B12 on Central Nervous System Function and Development. In: Gaull, G.E. (eds) Biology of Brain Dysfunction. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-2667-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2667-0_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-2669-4
Online ISBN: 978-1-4684-2667-0
eBook Packages: Springer Book Archive